The Calmer Co Launches Taki Mai Kava Tinctures on Amazon USA
Filed with ASX · · 3 pages · English
Summary by 6ix AI
The Calmer Co International Limited has launched its Taki Mai kava tinctures on Amazon USA, marking a significant step in its U.S. product expansion. These tinctures are designed for modern wellness consumers and are produced using organic cane alcohol extraction and premium Noble Kava. The company anticipates strong growth in the U.S. market, with Amazon forecasting substantial increases in kava product sales. This announcement highlights the company's strategy to leverage e-commerce channels for its kava wellness portfolio.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Calmer Co International Limited on 6ix
In the deck
Earlier from Calmer Co International
- Woolworths Launches Fiji Kava Across Australia
- Significant Growth in Demand for TakiMai & FijiKava at Coles
- Successful Completion of the Entitlement Offer
- Fiji Kava to be Ranged Nationally in Woolworths Supermarkets
- Prospectus
Later from Calmer Co International
- $8m FY25 Revenue Result Achieved up 86% vs FY24
- Coles Retail Sales Up 81% in July
- The Calmer Co Secures Expanded Lease in Navua, Fiji
- Preliminary Final Report
- Jul/Aug Sales Momentum Builds on H2FY25 Ops Turnaround
Follow Calmer Co International into a list and get an email when it puts out news.
Follow Calmer Co International